TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02736305 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT02736305 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT02736305 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT02736305 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02736305 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02736305 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00259545 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT03335384 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01279434 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00562133 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT00562133 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04355351 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00001984 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT02464033 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT02464033 — Predictive Biomarker (PRD): GAD2 mRNA
Genes: GAD2; GAD65
Study NCT02464033 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00834028 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00834028 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT00834028 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03071055 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00028743 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT00196729 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT01520493 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01520493 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03885830 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT03885830 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01380041 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04819217 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT01401192 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01207037 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04529733 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT02939547 — Predictive Biomarker (PRD): NPC1 mRNA
Genes: NPC1
Study NCT02779478 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT00342030 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study NCT01605188 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02600338 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00005984 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01254253 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study NCT06415006 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06049966 — Safety Biomarker (SAF): miR-375
Genes: MIR375
Study NCT03003039 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03494400 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00173407 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04301375 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01328613 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02474446 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT04497194 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04497194 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03425071 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03425071 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05280886 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT01047423 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01813370 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT00747825 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT00030940 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT01650246 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT02134977 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01491672 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02782403 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03217643 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT02946970 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT02946970 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT05084443 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04593316 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03489473 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT03489473 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03082742 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02905084 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02882113 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT02780401 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02780401 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00299312 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study NCT00299312 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study NCT00299312 — Predictive Biomarker (PRD): FOXG1 mRNA
Genes: FOXG1; FKH2; FKHL1; FKHL2; FKHL3; FKHL4; FOXG1A; FOXG1B; FOXG1C
Study NCT04592666 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01570036 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01570036 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02763410 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT02763410 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03399487 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT03399487 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03399487 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03399487 — Predictive Biomarker (PRD): SLC34A2 mRNA
Genes: SLC34A2
Study NCT03399487 — Predictive Biomarker (PRD): CD74 mRNA
Genes: CD74; DHLAG
Study NCT03399487 — Predictive Biomarker (PRD): SDC4 mRNA
Genes: SDC4
Study NCT03399487 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02175004 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT02175004 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT02038543 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT02686905 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00911482 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00911482 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000459 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02394340 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03760029 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00850785 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00568802 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT00900744 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01355393 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01355393 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03940820 — Predictive Biomarker (PRD): ROBO1 mRNA
Genes: ROBO1; DUTT1
Study NCT03637140 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03392896 — Predictive Biomarker (PRD): PHC1 mRNA
Genes: PHC1; EDR1; PH1
Study NCT03900832 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00063154 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04011618 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00681330 — Predictive Biomarker (PRD): TTK mRNA
Genes: TTK; MPS1; MPS1L1
Study NCT00681330 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT01832233 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02070887 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT01980550 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT01243853 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT01162824 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03581942 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03581942 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04218968 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT01605266 — Predictive Biomarker (PRD): GNL3 mRNA
Genes: GNL3; E2IG3; NS
Study NCT04246320 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03303716 — Predictive Biomarker (PRD): ASXL1 mRNA
Genes: ASXL1; KIAA0978
Study NCT03303716 — Predictive Biomarker (PRD): ASXL2 mRNA
Genes: ASXL2; ASXH2; KIAA1685
Study NCT03303716 — Predictive Biomarker (PRD): ASXL3 mRNA
Genes: ASXL3; KIAA1713
Study NCT02339961 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01682382 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study NCT01313689 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04160767 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03532542 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03631160 — Predictive Biomarker (PRD): SP6 mRNA
Genes: SP6; KLF14
Study NCT00461136 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00461136 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00109538 — Surrogate Endpoint (SUR): Hematologic response
Study NCT05304169 — Surrogate Endpoint (SUR): Plasma testosterone level
Study NCT03403296 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT00276991 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02695095 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT01187017 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04306471 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04306471 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00330577 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04605601 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT05045885 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01826929 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03383276 — Safety Biomarker (SAF): Interleukin 1
Study NCT01014260 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01014260 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01014260 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT02208427 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01304264 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02212639 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT01293903 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00388986 — Predictive Biomarker (PRD): GK mRNA
Genes: GK
Study NCT02308020 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02146456 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT01432717 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04187898 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study NCT00287898 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00287898 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT01574209 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01716442 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00473928 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02835794 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03195946 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03195946 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT03195946 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03195946 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01809847 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT06049641 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06049641 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01286675 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01286675 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01893996 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00758056 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study NCT00758056 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study NCT01535950 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01402089 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02091362 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04418791 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04418791 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00219076 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01754311 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT02396524 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03742700 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03742700 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT02876198 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02876198 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02767713 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01382394 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01382394 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04667897 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03942289 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06103396 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03718910 — Predictive Biomarker (PRD): DDX3X mRNA
Genes: DDX3X; DBX; DDX3
Study NCT04472052 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00994877 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT02553304 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02553304 — Predictive Biomarker (PRD): BIRC3 mRNA
Genes: BIRC3; API2; MIHC; RNF49
Study NCT02553304 — Predictive Biomarker (PRD): ZAP70 mRNA
Genes: ZAP70; SRK
Study NCT02553304 — Predictive Biomarker (PRD): KITLG mRNA
Genes: KITLG; MGF; SCF
Study NCT02125708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02125708 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00517582 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04443062 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02409563 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03549442 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04057547 — Predictive Biomarker (PRD): INAVA mRNA
Genes: INAVA; C1orf106
Study NCT04057547 — Predictive Biomarker (PRD): ARF6 mRNA
Genes: ARF6
Study NCT02719808 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01222260 — Surrogate Endpoint (SUR): Hematologic response
Study NCT00276029 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03057054 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT03721055 — Predictive Biomarker (PRD): SLC1A5 mRNA
Genes: SLC1A5; ASCT2; M7V1; RDR; RDRC
Study NCT02278120 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02278120 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02278120 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02278120 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02401516 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00593957 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study NCT04085315 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04085315 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT03511313 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04568720 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04530734 — Predictive Biomarker (PRD): UGT2B15 mRNA
Genes: UGT2B15; UGT2B8
Study NCT03371095 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01916512 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study NCT01916512 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03230526 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT01978977 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05173025 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02129439 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04122339 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study NCT04411030 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00801736 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT04662385 — Safety Biomarker (SAF): Interleukin 1
Study NCT01770457 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01770457 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study NCT01770457 — Predictive Biomarker (PRD): LIF mRNA
Genes: LIF; HILDA
Study NCT01770457 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03063723 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT00743275 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT02688673 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT00733993 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study NCT04123392 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05874115 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04159337 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT00321113 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04187053 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT01522313 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03101280 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT04706650 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00093808 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04208776 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02154009 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01205217 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01026844 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01026844 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03441620 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT01446159 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01446159 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00500903 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT04300101 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT04300101 — Predictive Biomarker (PRD): IRF4 mRNA
Genes: IRF4; MUM1
Study NCT00655694 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT02366026 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02366026 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell